CAS No. : 2130958-55-1
(Synonyms: Alflutinib (mesylate); Furmonertinib (mesylate); AST2818 (mesylate))
| Size | Price | Stock |
|---|---|---|
| 5mg | $160 | In-stock |
| 10mg | $240 | In-stock |
| 25mg | $480 | In-stock |
| 50mg | $720 | In-stock |
| 100mg | $970 | In-stock |
| 500mg | $2120 | In-stock |
| 1g | $2970 | In-stock |
| 5 g | Get quote | |
| 10 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-112870A |
| M.Wt: | 664.70 |
| Formula: | C29H35F3N8O5S |
| Purity: | >98 % |
| Solubility: | DMSO : 5 mg/mL (ultrasonic) |
Firmonertinib (Alflutinib; Furmonertinib) mesylate is is an orally active, mutant-selective, and blood-brain barrier penetrant EGFR inhibitor. Firmonertinib mesylate inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib mesylate has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins mutation[1]. IC50 & Target:EGFR[1] In Vitro:Firmonertinib mesylate can inhibit EGFR active mutations as well as the T790M acquired resistant mutation[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.